(a) In generalThe Attorney General shall, on a semiannual basis, submit to the congressional committees and organizations specified in subsection (b) reports that—(1) describe the allocation of the resources of the Drug Enforcement Administration and the Federal Bureau of Investigation for the investigation and prosecution of alleged violations of the Controlled Substances Act [21 U.S.C. 801 et seq.] involving methamphetamine; and
(2) the measures being taken to give priority in the allocation of such resources to such violations involving—(A) persons alleged to have imported into the United States substantial quantities of methamphetamine or scheduled listed chemicals (as defined pursuant to the amendment made by section 711(a)(1)); 11 See References in Text note below.
(B) persons alleged to have manufactured methamphetamine; and
(C) circumstances in which the violations have endangered children.
(b) Congressional committeesThe congressional committees and organizations referred to in subsection (a) are—(1) in the House of Representatives, the Committee on the Judiciary, the Committee on Energy and Commerce, and the Committee on Government Reform; and
(2) in the Senate, the Committee on the Judiciary, the Committee on Commerce, Science, and Transportation, and the Caucus on International Narcotics Control.
Structure US Code
CHAPTER 13— DRUG ABUSE PREVENTION AND CONTROL
SUBCHAPTER I— CONTROL AND ENFORCEMENT
Part E— Administrative and Enforcement Provisions
§ 871a. Semiannual reports to Congress
§ 872. Education and research programs of Attorney General
§ 872a. Public-private education program
§ 873. Cooperative arrangements
§ 875. Administrative hearings
§ 878. Powers of enforcement personnel
§ 880. Administrative inspections and warrants
§ 883. Enforcement proceedings
§ 885. Burden of proof; liabilities
§ 886a. Diversion Control Fee Account
§ 887. Coordination and consolidation of post-seizure administration
§ 889. Production control of controlled substances
§ 890. Review of Federal sales of chemicals usable to manufacture controlled substances